Literature DB >> 10146955

Costing wound infection in a Scottish hospital.

W Lynch1, M Malek, P G Davey, D J Byrne, A Napier.   

Abstract

Data from a trial of preoperative whole body disinfection in postoperative wound infection prophylaxis involving 3733 patients were used to analyse the cost of a postoperative wound infection. The overall wound infection rate was 14.73% (513/3482), 61% of which were diagnosed after hospital discharge (312 outpatient infections versus 201 inpatient infections). This highlights the prevalence of the transfer of the cost of wound infection to the community. The inpatient and outpatient costs were calculated separately for those with and without a wound infection. Operative procedures were placed into 38 different categories. 12 of these 38 categories accounted for over 90% of the total number of operations performed. Overall, infected patients cost society more than noninfected patients. The hospitalisation costs for inpatients for all categories of patients, whether infected or not, comprised over 99% of the total cost. The excess cost for the infected patients in the study was calculated as 312 915 British pounds sterling (1990 British pounds sterling) or 610 British pounds sterling per infected patient, equivalent to 1926 hospital days overall. For some operations (e.g. stripping varicose veins) an excess of 52 hospital days were associated with wound infection diagnosed after discharge from hospital. Wound infections in some operative categories were consistently more expensive to manage (e.g. excess cost/infected vascular patient = 1085 British pounds sterling) while other operative categories had less costly wound infections (e.g. excess cost/infected thyroid patient = 110 British pounds sterling).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 10146955     DOI: 10.2165/00019053-199202020-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  9 in total

1.  The importance of surveillance after discharge from hospital in the diagnosis of postoperative wound infection.

Authors:  D J Law; S F Mishriki; P J Jeffery
Journal:  Ann R Coll Surg Engl       Date:  1990-05       Impact factor: 1.891

2.  Postoperative complications: how much do they cost?

Authors:  M N de la Hunt; A Y Chan; S J Karran
Journal:  Ann R Coll Surg Engl       Date:  1986-07       Impact factor: 1.891

3.  Prospective payment and infection control.

Authors:  B E Beyt; S Troxler; J Cavaness
Journal:  Infect Control       Date:  1985-04

4.  A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis.

Authors:  A P Wilson; T Treasure; M F Sturridge; R N Grüneberg
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Costs of nosocomial infection in a neonatal unit.

Authors:  R Girard; J Fabry; R Meynet; D C Lambert; M Sepetjan
Journal:  J Hosp Infect       Date:  1983-12       Impact factor: 3.926

6.  Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs.

Authors:  R Knill-Jones; M Drummond; H Kohli; L Davies
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

7.  Hospital costs of nosocomial infections: a prospective three-month study in a community hospital.

Authors:  W E Scheckler
Journal:  Infect Control       Date:  1980 May-Jun

8.  High cost nosocomial infections.

Authors:  R W Pinner; R W Haley; B A Blumenstein; D R Schaberg; S D Von Allmen; J E McGowan
Journal:  Infect Control       Date:  1982 Mar-Apr

9.  Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients.

Authors:  R W Haley; T M Hooton; D H Culver; R C Stanley; T G Emori; C D Hardison; D Quade; R H Shachtman; D R Schaberg; B V Shah; G D Schatz
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

  9 in total
  5 in total

Review 1.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

2.  Antibiotic policies. Economics and effectiveness from a UK perspective.

Authors:  P Davey
Journal:  Drugs       Date:  1996       Impact factor: 9.546

3.  Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.

Authors:  John C Woodfield; Andre M Van Rij; Ross A Pettigrew; Antje van der Linden; Donna Bolt
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

4.  The cost effectiveness of amoxicillin/clavulanic acid as antibacterial prophylaxis in abdominal and gynaecological surgery.

Authors:  P G Davey; S E Parker; I K Crombie; M Jaderberg
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

5.  Is perioperative antibiotic prophylaxis in the case of routine surgical removal of the third molar still justified? A randomized, double-blind, placebo-controlled clinical trial with a split-mouth design.

Authors:  Barbara Kirnbauer; Norbert Jakse; Astrid Truschnegg; Ivana Dzidic; Khaled Mukaddam; Michael Payer
Journal:  Clin Oral Investig       Date:  2022-07-06       Impact factor: 3.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.